ArticleClinical and translational radiation oncology2021
Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis.
Amit Roy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.